Latest News & Features
Americas
Pharmaceutical company AstraZeneca has filed a patent infringement lawsuit against drug maker Pharmadax after it applied to market a generic version of a schizophrenia and bipolar disorder treatment. 27 October 2014
Generics
A US court has rejected attempts by two companies to market generic versions of a birth control pill owned by pharmaceutical company Actavis. 24 October 2014
Generics
The South African government has been urged to act quickly and honour its plans to overhaul its patent laws, which some have claimed could lead to an increase in affordable generic medicines. 23 October 2014
Americas
Pharmaceutical company Eli Lilly has said its profits fell by more than 50% in the most recent quarter, citing patent expirations and generic competition as contributing factors. 23 October 2014
Big Pharma
Pharmaceutical company Roche has announced it will be building a new multi-billion research and development centre. 22 October 2014
Americas
The US Court of Appeals for the Federal Circuit has limited a judge’s power to enforce local rules in a patent dispute involving pharmaceutical company Pfizer and an anti-cancer treatment company. 21 October 2014
Big Pharma
Pharmaceutical and biologics company AstraZeneca and the University of Cambridge have teamed up as part of a programme aimed at increasing life science-related research and teaching. 20 October 2014
Americas
The US Supreme Court was split yesterday (October 15) after hearing arguments in a high-profile case that will determine whether generic drug companies are free to market a cheaper version of Teva’s blockbuster multiple sclerosis drug. 16 October 2014
Americas
Biotechnology company Capricor Therapeutics has agreed to acquire patents from medical equipment maker Medtronic as part of plans to develop a programme to treat heart failure. 15 October 2014
Americas
The highest court in the US will hear a dispute today (October 15) between pharmaceutical company Teva and generic rivals that are looking to market versions of its multiple sclerosis drug Copaxone (glatiramer acetate). 15 October 2014